Wells Fargo & Company Oric Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,779 shares of ORIC stock, worth $264,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,779

Previous 15,217 75.98%

Holding current value

$264,844

Previous $209,000 9.57%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.63 - $12.93 $76,656 - $149,496	11,562 Added 75.98%	26,779 $189,000
Q1 2024 May 10, 2024	BUY	$8.04 - $16.03 $14,359 - $28,629	1,786 Added 13.3%	15,217 $209,000
Q4 2023 Feb 09, 2024	BUY	$5.41 - $9.43 $11,480 - $20,010	2,122 Added 18.76%	13,431 $123,000
Q3 2023 Nov 13, 2023	SELL	$6.05 - $9.28 $31,284 - $47,986	-5,171 Reduced 31.38%	11,309 $68,000
Q2 2023 Aug 15, 2023	BUY	$4.95 - $8.4 $72,270 - $122,640	14,600 Added 776.6%	16,480 $127,000
Q1 2023 May 12, 2023	BUY	$4.26 - $6.75 $6,096 - $9,659	1,431 Added 318.71%	1,880 $10,000
Q4 2022 Feb 13, 2023	BUY	$2.41 - $5.89 $12 - $29	5 Added 1.13%	449 $2,000
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $252 - $419	-80 Reduced 15.27%	444 $2,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.07 $480,068 - $1.26 Million	-177,803 Reduced 99.71%	524 $2,000
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $17,406 - $61,727	-3,834 Reduced 2.1%	178,327 $953,000
Q4 2021 Feb 14, 2022	SELL	$12.01 - $20.3 $12.3 Million - $20.8 Million	-1,026,631 Reduced 84.93%	182,161 $2.68 Million
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $516,575 - $819,372	-32,489 Reduced 2.62%	1,208,792 $25.3 Million
Q2 2021 Aug 16, 2021	BUY	$17.37 - $25.34 $652,069 - $951,263	37,540 Added 3.12%	1,241,281 $22 Million
Q1 2021 May 13, 2021	BUY	$23.67 - $36.85 $8.28 Million - $12.9 Million	349,935 Added 40.99%	1,203,741 $29.5 Million
Q4 2020 Feb 09, 2021	BUY	$20.32 - $39.8 $4.67 Million - $9.15 Million	229,870 Added 36.84%	853,806 $28.9 Million
Q3 2020 Nov 05, 2020	BUY	$19.5 - $31.26 $1.03 Million - $1.66 Million	52,975 Added 9.28%	623,936 $15.6 Million
Q2 2020 Aug 13, 2020	BUY	$25.68 - $38.12 $14.7 Million - $21.8 Million	570,961 New	570,961 $19.3 Million

Others Institutions Holding ORIC

# of Institutions

112

Shares Held

63.1M

Call Options Held

Put Options Held

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $391M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Oric Pharmaceuticals, Inc. Transaction History